Agios Pharmaceuticals AGIO
NASDAQ AGIO
$33.26 +0.13 (+0.38%)
As of: Sep 4, 2026 · 3:18 PM EDT

Agios Pharmaceuticals (AGIO) Current Deferred Tax Assets (2012 - 2013)

Agios Pharmaceuticals' (AGIO) quarterly Current Deferred Tax Assets came in at $1.2 million in Q3 2013, little changed on a QoQ basis from $1.2 million in Q2 2013.

Analysis

Agios Pharmaceuticals (AGIO) Current Deferred Tax Assets (2012 - 2013) Analysis & Trends

Agios Pharmaceuticals (AGIO) has 2 years of Current Deferred Tax Assets data on file, last reported at $1.2 million in Q3 2013.

  • Quarterly Current Deferred Tax Assets changed N/A year-over-year to $1.2 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $1.2 million (changed N/A YoY) and the FY2012 annual result came in at $1.2 million, changed N/A from the prior year.
  • Current Deferred Tax Assets steadied at $1.2 million in Q3 2013, from $1.2 million in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $1.2 million in Q2 2013 to a low of $1.2 million in Q4 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Agios Pharmaceuticals 1.97 Bn 1.97 Bn 41.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 1.25 Mn
Jun 30, 2013 1.25 Mn
Dec 31, 2012 1.25 Mn